Logo

Chronic Hepatitis C in Saudi Arabia: Three Years Local Experience in a University Hospital

Authors:
Hisham O AkbarHisham O Akbar1,*, Ahmad Al GhamdiAhmad Al Ghamdi2, Faten QattanFaten Qattan2, Hind I FallatahHind I Fallatah1, Maha Al RumaniMaha Al Rumani2
1Department of Internal Medicine, King Abdul Aziz University Hospital, gihepa@yahoo.com, Saudi Arabia
2Molecular Biology Department, King Abdul Aziz University Hospital, Saudi Arabia


Hepatitis Monthly:Vol. 12, issue 9; 6178
Published online:Sep 30, 2012
Article type:Research Article
Received:May 23, 2012
Accepted:Jul 28, 2012
How to Cite:Hisham O AkbarAhmad Al GhamdiFaten QattanHind I FallatahMaha Al RumaniChronic Hepatitis C in Saudi Arabia: Three Years Local Experience in a University Hospital.12(9):6178.https://doi.org/10.5812/hepatmon.6178.

Abstract

Background:

Chronic hepatitis C (CHC) is a global infection. In Saudi Arabia, the prevalence of CHC is declining due to the implementation of a blood screening program. However, CHC still remains a leading cause of liver cirrhosis and hepatocellular carcinoma.

Objectives:

This is a retrospective study of CHC patients at the King Abdul Aziz University Hospital, Jeddah, Saudi Arabia.

Patients and Methods:

Out of a total of 291 CHC patients from the hepatology clinic at King Abdul Aziz University hospital, Jeddah, 279 patients were included in the present study. They were primarily male (152, 54.5%), with a mean age of 50.41 1.72 years. The majority of patients were either Saudi (108, 38.7%) or Egyptian (60, 21.5%). A total of 61 patients received combination treatment with pegylated interferon and ribavirin, and one patient with sickle-cell anemia received pegylated INF monotherapy. Demographic, clinical and laboratory features of the CHC patients, and their responses to treatment were studied.

Results:

Decompensated cirrhosis was documented in 60 patients (21.5%), and hepatocellular carcinoma in 14 (5%). The mean level of serum alanine aminotransferase was 83.6 231 u/L. The predominant genotype among the 70 patients tested, was genotype 4, followed by genotype 1 (39 and 18 patients, respectively). The sustained viral response (SVR) rate was 82.99%. The main predictive factors for SVR were baseline HCV viral load and rapid virologic response (RVR). The mean duration of follow-up was 4.2 .85 years. There were 24 patients who had liver disease-related mortality.

Conclusions:

our data showed that 22% of CHC patients progress to cirrhosis and another 22% had treatment. Liver related mortality was more common in patients with advanced cirrhosis.

Full Text

Full text is available in PDF

comments

Leave a comment here


Crossmark
Crossmark
Checking
Share on
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles